Multiple Choice | |||||
Q# | Topic | Max Pts | <=50% | 51%-70% | >70% |
- | Alternative Investments | 8 | - | - | * |
- | Corporate Finance | 20 | - | - | * |
- | Derivatives | 12 | - | - | * |
- | Economics | 24 | - | - | * |
- | Equity Investments | 24 | - | - | * |
- | Ethical & Professional Standards | 36 | - | - | * |
- | Financial Reporting & Analysis | 48 | - | - | * |
- | Fixed Income Investments | 28 | - | - | * |
- | Portfolio Management | 12 | - | - | * |
- | Quantitative Methods | 28 | - | - | * |
Item Set | |||||
Q# | Topic | Max Pts | <=50% | 51%-70% | >70% |
- | Alternative Investments | 18 | - | - | * |
- | Corporate Finance | 36 | - | - | * |
- | Derivatives | 36 | - | - | * |
- | Economics | 18 | - | - | * |
- | Equity Investments | 72 | - | - | * |
- | Ethical & Professional Standards | 36 | - | - | * |
- | Financial Reporting & Analysis | 72 | - | - | * |
- | Fixed Income Investments | 36 | - | - | * |
- | Portfolio Management | 18 | - | - | * |
- | Quantitative Methods | 18 | - | - | * |
Essay | |||||
Q# | Topic | Max Pts | <=50% | 51%-70% | >70% |
1 | Portfolio Management - Individual | 27 | - | - | * |
2 | Portfolio Management - Individual | 9 | - | * | - |
3 | Portfolio Management - Execution | 21 | - | - | * |
4 | Portfolio Management - Individual | 17 | - | - | * |
5 | Economics | 24 | - | - | * |
6 | Portfolio Management - Institutional | 34 | - | * | - |
7 | Fixed Income Investments | 23 | - | - | * |
8 | Derivatives | 13 | - | - | * |
9 | Derivatives | 12 | - | - | * |
Item Set | |||||
Q# | Topic | Max Pts | <=50% | 51%-70% | >70% |
- | Alternative Investments | 18 | - | - | * |
- | Equity Investments | 18 | - | - | * |
- | Ethical & Professional Standards | 36 | - | - | * |
- | Fixed Income Investments | 18 | - | - | * |
- | Portfolio Management | 18 | - | - | * |
- | Portfolio Management - Asset Allocation | 18 | - | - | * |
- | Portfolio Management - Individual | 18 | - | - | * |
- | Portfolio Management - Performance Eval. | 18 | - | - | * |
- | Portfolio Management - Risk Management | 18 | - | - | * |
欢迎光临 CFA论坛 (http://forum.theanalystspace.com/) | Powered by Discuz! 7.2 |